Global Recombinant Human Follicle-stimulating Hormone Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 31 Dec 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Recombinant Human Follicle-stimulating Hormone market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Recombinant Human Follicle-stimulating Hormone market size and forecasts, in consumption value ($ Million), 2018-2029
Global Recombinant Human Follicle-stimulating Hormone market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Recombinant Human Follicle-stimulating Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Recombinant Human Follicle-stimulating Hormone market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Follicle-stimulating Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Follicle-stimulating Hormone market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ferring, Livzon, Gedeon Richter and GenSci, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Recombinant Human Follicle-stimulating Hormone market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    75IU
    150IU
    Others

Market segment by Application
    Infertility Treatment
    Assisted Reproductive Technology

Market segment by players, this report covers
    Merck
    Ferring
    Livzon
    Gedeon Richter
    GenSci
    Teva
    ChangChun High & New Technology
    ABL
    Scripps Laboratories
    Alphamab Oncology
    Hunan Jingfeng Pharmaceutical
    Qilu Pharmaceutical
    Beijing SL Pharmaceutical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Recombinant Human Follicle-stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant Human Follicle-stimulating Hormone, with revenue, gross margin and global market share of Recombinant Human Follicle-stimulating Hormone from 2018 to 2023.
Chapter 3, the Recombinant Human Follicle-stimulating Hormone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Recombinant Human Follicle-stimulating Hormone market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Human Follicle-stimulating Hormone.
Chapter 13, to describe Recombinant Human Follicle-stimulating Hormone research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Human Follicle-stimulating Hormone
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Recombinant Human Follicle-stimulating Hormone by Type
        1.3.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type in 2022
        1.3.3 75IU
        1.3.4 150IU
        1.3.5 Others
    1.4 Global Recombinant Human Follicle-stimulating Hormone Market by Application
        1.4.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Infertility Treatment
        1.4.3 Assisted Reproductive Technology
    1.5 Global Recombinant Human Follicle-stimulating Hormone Market Size & Forecast
    1.6 Global Recombinant Human Follicle-stimulating Hormone Market Size and Forecast by Region
        1.6.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region, (2018-2029)
        1.6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2018-2029)
        1.6.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2018-2029)
        1.6.6 South America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Merck Recent Developments and Future Plans
    2.2 Ferring
        2.2.1 Ferring Details
        2.2.2 Ferring Major Business
        2.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Ferring Recent Developments and Future Plans
    2.3 Livzon
        2.3.1 Livzon Details
        2.3.2 Livzon Major Business
        2.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Livzon Recent Developments and Future Plans
    2.4 Gedeon Richter
        2.4.1 Gedeon Richter Details
        2.4.2 Gedeon Richter Major Business
        2.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Gedeon Richter Recent Developments and Future Plans
    2.5 GenSci
        2.5.1 GenSci Details
        2.5.2 GenSci Major Business
        2.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 GenSci Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 ChangChun High & New Technology
        2.7.1 ChangChun High & New Technology Details
        2.7.2 ChangChun High & New Technology Major Business
        2.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 ChangChun High & New Technology Recent Developments and Future Plans
    2.8 ABL
        2.8.1 ABL Details
        2.8.2 ABL Major Business
        2.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 ABL Recent Developments and Future Plans
    2.9 Scripps Laboratories
        2.9.1 Scripps Laboratories Details
        2.9.2 Scripps Laboratories Major Business
        2.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Scripps Laboratories Recent Developments and Future Plans
    2.10 Alphamab Oncology
        2.10.1 Alphamab Oncology Details
        2.10.2 Alphamab Oncology Major Business
        2.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Alphamab Oncology Recent Developments and Future Plans
    2.11 Hunan Jingfeng Pharmaceutical
        2.11.1 Hunan Jingfeng Pharmaceutical Details
        2.11.2 Hunan Jingfeng Pharmaceutical Major Business
        2.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
    2.12 Qilu Pharmaceutical
        2.12.1 Qilu Pharmaceutical Details
        2.12.2 Qilu Pharmaceutical Major Business
        2.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
    2.13 Beijing SL Pharmaceutical
        2.13.1 Beijing SL Pharmaceutical Details
        2.13.2 Beijing SL Pharmaceutical Major Business
        2.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Beijing SL Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Recombinant Human Follicle-stimulating Hormone Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Recombinant Human Follicle-stimulating Hormone by Company Revenue
        3.2.2 Top 3 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2022
        3.2.3 Top 6 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2022
    3.3 Recombinant Human Follicle-stimulating Hormone Market: Overall Company Footprint Analysis
        3.3.1 Recombinant Human Follicle-stimulating Hormone Market: Region Footprint
        3.3.2 Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
        3.3.3 Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Recombinant Human Follicle-stimulating Hormone Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2023)
    5.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2029)
    6.2 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2029)
    6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country
        6.3.1 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2029)
        6.3.2 United States Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2029)
    7.2 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2029)
    7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country
        7.3.1 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2029)
        7.3.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        7.3.3 France Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        7.3.5 Russia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        7.3.6 Italy Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region
        8.3.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2018-2029)
        8.3.2 China Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        8.3.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        8.3.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        8.3.5 India Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        8.3.7 Australia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2029)
    9.2 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2029)
    9.3 South America Recombinant Human Follicle-stimulating Hormone Market Size by Country
        9.3.1 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2029)
        9.3.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        9.3.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country
        10.3.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2029)
        10.3.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)
        10.3.4 UAE Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Recombinant Human Follicle-stimulating Hormone Market Drivers
    11.2 Recombinant Human Follicle-stimulating Hormone Market Restraints
    11.3 Recombinant Human Follicle-stimulating Hormone Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Recombinant Human Follicle-stimulating Hormone Industry Chain
    12.2 Recombinant Human Follicle-stimulating Hormone Upstream Analysis
    12.3 Recombinant Human Follicle-stimulating Hormone Midstream Analysis
    12.4 Recombinant Human Follicle-stimulating Hormone Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Merck Company Information, Head Office, and Major Competitors
    Table 6. Merck Major Business
    Table 7. Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 8. Merck Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Merck Recent Developments and Future Plans
    Table 10. Ferring Company Information, Head Office, and Major Competitors
    Table 11. Ferring Major Business
    Table 12. Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 13. Ferring Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Ferring Recent Developments and Future Plans
    Table 15. Livzon Company Information, Head Office, and Major Competitors
    Table 16. Livzon Major Business
    Table 17. Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 18. Livzon Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Livzon Recent Developments and Future Plans
    Table 20. Gedeon Richter Company Information, Head Office, and Major Competitors
    Table 21. Gedeon Richter Major Business
    Table 22. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 23. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Gedeon Richter Recent Developments and Future Plans
    Table 25. GenSci Company Information, Head Office, and Major Competitors
    Table 26. GenSci Major Business
    Table 27. GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 28. GenSci Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. GenSci Recent Developments and Future Plans
    Table 30. Teva Company Information, Head Office, and Major Competitors
    Table 31. Teva Major Business
    Table 32. Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 33. Teva Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Teva Recent Developments and Future Plans
    Table 35. ChangChun High & New Technology Company Information, Head Office, and Major Competitors
    Table 36. ChangChun High & New Technology Major Business
    Table 37. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 38. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. ChangChun High & New Technology Recent Developments and Future Plans
    Table 40. ABL Company Information, Head Office, and Major Competitors
    Table 41. ABL Major Business
    Table 42. ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 43. ABL Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. ABL Recent Developments and Future Plans
    Table 45. Scripps Laboratories Company Information, Head Office, and Major Competitors
    Table 46. Scripps Laboratories Major Business
    Table 47. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 48. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Scripps Laboratories Recent Developments and Future Plans
    Table 50. Alphamab Oncology Company Information, Head Office, and Major Competitors
    Table 51. Alphamab Oncology Major Business
    Table 52. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 53. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Alphamab Oncology Recent Developments and Future Plans
    Table 55. Hunan Jingfeng Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 56. Hunan Jingfeng Pharmaceutical Major Business
    Table 57. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 58. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
    Table 60. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 61. Qilu Pharmaceutical Major Business
    Table 62. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 63. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Qilu Pharmaceutical Recent Developments and Future Plans
    Table 65. Beijing SL Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 66. Beijing SL Pharmaceutical Major Business
    Table 67. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 68. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Beijing SL Pharmaceutical Recent Developments and Future Plans
    Table 70. Global Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Recombinant Human Follicle-stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Recombinant Human Follicle-stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Recombinant Human Follicle-stimulating Hormone Players
    Table 75. Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
    Table 76. Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
    Table 77. Recombinant Human Follicle-stimulating Hormone New Market Entrants and Barriers to Market Entry
    Table 78. Recombinant Human Follicle-stimulating Hormone Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Recombinant Human Follicle-stimulating Hormone Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Type (2018-2023)
    Table 81. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023)
    Table 83. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Recombinant Human Follicle-stimulating Hormone Raw Material
    Table 115. Key Suppliers of Recombinant Human Follicle-stimulating Hormone Raw Materials
List of Figures
    Figure 1. Recombinant Human Follicle-stimulating Hormone Picture
    Figure 2. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type in 2022
    Figure 4. 75IU
    Figure 5. 150IU
    Figure 6. Others
    Figure 7. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application in 2022
    Figure 9. Infertility Treatment Picture
    Figure 10. Assisted Reproductive Technology Picture
    Figure 11. Global Recombinant Human Follicle-stimulating Hormone Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Recombinant Human Follicle-stimulating Hormone Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Recombinant Human Follicle-stimulating Hormone Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region in 2022
    Figure 16. North America Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players in 2022
    Figure 22. Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Recombinant Human Follicle-stimulating Hormone Market Share in 2022
    Figure 24. Global Top 6 Players Recombinant Human Follicle-stimulating Hormone Market Share in 2022
    Figure 25. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Type (2018-2023)
    Figure 26. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Type (2024-2029)
    Figure 27. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Application (2018-2023)
    Figure 28. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Application (2024-2029)
    Figure 29. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Recombinant Human Follicle-stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 63. Recombinant Human Follicle-stimulating Hormone Market Drivers
    Figure 64. Recombinant Human Follicle-stimulating Hormone Market Restraints
    Figure 65. Recombinant Human Follicle-stimulating Hormone Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Recombinant Human Follicle-stimulating Hormone in 2022
    Figure 68. Manufacturing Process Analysis of Recombinant Human Follicle-stimulating Hormone
    Figure 69. Recombinant Human Follicle-stimulating Hormone Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical

Related Reports

Global Recombinant Human Follicle-stimulating Hormone Supply, Demand and Key Producers, 2023-2029

Global Recombinant Human Follicle-stimulating Hormone Supply, Demand and Key Producers, 2023-2029

date 19 Feb 2023

date Pharma & Healthcare

The global Recombinant Human Follicle-stimulating Hormone market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Recombinant Human Follicle-stimulating Hormone Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Recombinant Human Follicle-stimulating Hormone Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD 1075.9 million in 2023 and is forecast to a readjusted size of USD 1550.5 million by 2030 with a CAGR of 5.4% during review period.

Product Tags

recombinant human follicle stimulating hormone

Recombinant Human Follicle-stimulating Hormone

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>